Rina-S (rinatabart sesutecan) - Genmab
Rina-S: Initiation of P3 trial for 2L endometrial cancer by end of 2025 (Genmab A/S) - May 9, 2025 - Q1 2025 Results 
New P3 trial • Endometrial Cancer • Oncology
https://ir.genmab.com/static-files/4eb667d6-6c47-4e11-ab4a-72c83cf8fd79
 
May 9, 2025
 
 
510412a6-0657-4187-8304-b46ca9f4aa5b.png